Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-16
2010-06-01
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S366000, C546S268400, C548S146000, C548S215000, C548S335100, C514S252130, C514S365000, C514S374000, C514S396000
Reexamination Certificate
active
07728009
ABSTRACT:
Thiazole amides, imidazole amides and related analogues of the Formula:are provided, in which variables are as described herein. Such compounds may be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of central nervous system (CNS) and other disorders in humans, domesticated companion animals and livestock animals. Compounds provided herein may be administered alone or in combination with one or more other CNS agents to potentiate the effects of the other CNS agent(s). Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting histamine H3 receptors (e.g., receptor localization studies).
REFERENCES:
patent: 2858318 (1958-10-01), Stoll et al.
patent: 3331830 (1967-07-01), Tomcufcik et al.
patent: 3651054 (1972-03-01), Crovetti et al.
patent: 4123541 (1978-10-01), Ohata et al.
patent: 4260765 (1981-04-01), Harrison et al.
patent: 4804668 (1989-02-01), Takase et al.
patent: 6100279 (2000-08-01), Vaccaro et al.
patent: 6288230 (2001-09-01), Chen et al.
patent: 6962936 (2005-11-01), Hale et al.
patent: 6995171 (2006-02-01), Autry et al.
patent: 7208497 (2007-04-01), Dorwald et al.
patent: 7223782 (2007-05-01), Atkinson et al.
patent: 2002/0004511 (2002-01-01), Luzzio et al.
patent: 2004/0132726 (2004-07-01), Arora et al.
patent: 54-030162 (1979-03-01), None
patent: 11-080107 (1999-03-01), None
patent: WO 98/15541 (1998-04-01), None
patent: WO 01/02385 (2001-01-01), None
patent: WO 01/32604 (2001-05-01), None
patent: WO 03/037332 (2003-05-01), None
patent: WO 2004/054973 (2004-07-01), None
patent: WO 2004/073594 (2004-09-01), None
patent: WO 2006/011042 (2006-02-01), None
patent: WO 2006/019833 (2006-02-01), None
Balestra et al. CAS: 145:124560.
Selwood et al.,2001, CAS: 134:353175.
Brown et al., 1982, CAS: 96:104173.
Mitsubishi et al., 1979, CAS: 91: 91633.
Harrison et al., 1973, CAS: 78:43468.
Jansen et al., 1961, CAS: 55:59494.
Kiss-Szikszai et al., (2001) Arkivoc (III) 40-50.
Vakula et al., (1973) Indian Journal of Chemistry, 11(8):732-34.
Jarvest et al., (1992) J. Heterocyclic Chem., 29(6):1401-03.
Haugwitz et al., (1985) J. Med. Chem., 28(9):1234-41.
Brown et al., (1981) Australian J. Chem., 34(11):2423-29.
Roy et al., (2004) Tetrahedron, 60(10):2301-10.
Haruta et al., (2002) Heterocycles, 58:79-83.
Ibata et al., (1989) Bull. Chemical Soc. Japan 62(2):618-620.
Donohue et al., (2002) J. Combinatorial Chemistry 4(1):23-32.
Witkiewicz et al., (1987) Polish J. Pharmacol. 39(6):715-20.
Gao Yang
Ge Ping
Lan Jiong
Ochterski Joseph W.
Peterson John M.
Cantor & Colburn LLP
Neurogen Corporation
Shiao Rei-tsang
LandOfFree
Thiazole amides, imidazole amides and related analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole amides, imidazole amides and related analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole amides, imidazole amides and related analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4162062